XBIT

XBIOTECH INC.

XBIT · CIK 1626878 · Annual (10-K) · Last 8 years

Financial Trends

Revenue
20172024
Net Income−$39M
20172024
Operating CF−$31M
20172024
Free Cash Flow−$32M
20172024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕FY 2017↕
Revenue————————
Cost of Revenue—$0.0B$0.0B$0.0B$0.0B———
Gross Profit—$0.0B$0.0B$0.0B$0.0B———
R&D Expense$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
SG&A Expense————————
Operating Income$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
Net Income$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$0.7B$-0.0B$-0.0B
EPS (Basic)$-1.26$-0.15$-0.10$-0.58$-0.36$16.67——
EPS (Diluted)$-1.26$-0.81$-1.08$-0.58$-0.36$14.82——

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕FY 2017↕
Total Assets$0.2B$0.2B$0.2B$0.3B$0.4B$0.8B$0.0B$0.1B
Current Assets$0.2B$0.2B$0.2B$0.2B$0.3B$0.7B$0.0B$0.0B
Cash & Equivalents$0.2B$0.2B$0.2B$0.2B$0.2B$0.7B$0.0B$0.0B
Total Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B$0.1B$0.0B$0.0B
Current Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B$0.1B$0.0B$0.0B
Stockholders' Equity$0.2B$0.2B$0.2B$0.3B$0.3B$0.8B$0.0B$0.1B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕FY 2017↕
Operating Cash Flow$-0.0B$-0.0B$-0.0B$0.1B$-0.1B$-0.0B$-0.0B$-0.0B
Investing Cash Flow$-0.0B$0.1B$-0.1B$-0.0B$-0.0B$0.7B$-0.0B$-0.0B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$0.0B$-0.0B$0.0B$-0.1B$-0.4B$0.0B$0.0B$0.0B
← Companies